Logo

American Heart Association

  15
  0


Final ID: MDP420

Deep Learning Enabled Electrocardiogram Aimed to Detect Coronary Artery Disease to Predict Atherosclerotic Cardiovascular Events in the Community

Abstract Body (Do not enter title and authors here): Background: We previously developed deep-learning algorithms that identify coronary artery disease (CAD) risk based on (i) coronary artery calcium (CAC), (ii) obstructive CAD by angiography, and (iii) left ventricular akinesis in ≥1 segment by echocardiogram, using a 12-lead electrocardiogram (CAD ECG-AI). We tested the hypothesis that those with increased probability of CAD by CAD ECG-AI algorithms will have an increased risk of atherosclerotic cardiovascular disease (ASCVD) events and would refine the AHA Predicting Risk of Cardiovascular Disease Events (PREVENTTM) equations’ predictive capabilities.

Methods: We assessed a group of consecutive patients who sought primary care in Olmsted County, MN, between 1997 and 2003. Passive follow-up was conducted using the Rochester Epidemiology Project's record linkage system. Patients included met the same criteria of the original PREVENTTM equations. The probability output of each CAD ECG-AI algorithm was used to predict ASCVD (fatal and non-fatal myocardial infarction and ischemic stroke) and ASCVD-Plus [further including percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and all-cause mortality]. Events were validated in duplicate. Cox proportional hazard models adjusted for age, sex, and risk factors while modeling each CAD ECG-AI algorithm as an individual and additive predictor (see footnote). PREVENTTM risk categories stratified analysis to evaluate the effect of the CAD ECG-AI models on predicted ASCVD risk.

Results: We included 21,193 patients, with mean ± SD age 51.6 ± 12.0, 54% women and 95% white. After 14.2±12.4 years follow-up, 1,351 (6.4%) developed ASCVD, and 2,808 (13.2%) had ASCVD-Plus. The risk of ASCVD and ASCVD-Plus increased with positivity for the CAD ECG-AI algorithms after adjustments for age, sex, and PREVENTTM equations factors, all p for trend <0.001 (data not shown). In additive analyses, the risk of ASCVD and ASCVD-Plus increased with increased CAD ECG-AI factors, all p for trend <0.001 (Fig. A-B). Furthermore, the CAD ECG-AI algorithm enhanced the predictive capabilities of PREVENTTM equations across most risk subgroups (Fig. C-E).

Conclusions: The deep-learning CAD ECG-AI algorithms displayed an independent and additive association
with long-term ASCVD and ASCVD-Plus events in the community and improved the PREVENTTM predicted ASCVD risk. The CAD ECG-AI algorithms could help identify individuals at risk in primary prevention of cardiovascular events.
  • Medina-inojosa, Jose  ( MAYO CLINIC , Rochester , Minnesota , United States )
  • Mangold, Kathryn  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Awasthi, Samir  ( Anumana , Boston , Massachusetts , United States )
  • Medina-inojosa, Betsy  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Mccully, Robert  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Lerman, Amir  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Attia, Zachi  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Friedman, Paul  ( MAYO CLINIC , Rochester , Minnesota , United States )
  • Lopez-jimenez, Francisco  ( MAYO CLINIC COLL MEDICINE , Rochester , Minnesota , United States )
  • Author Disclosures:
    Jose Medina-Inojosa: DO NOT have relevant financial relationships | Kathryn Mangold: DO NOT have relevant financial relationships | Samir Awasthi: No Answer | Betsy Medina-Inojosa: DO NOT have relevant financial relationships | Robert McCully: No Answer | Amir Lerman: DO NOT have relevant financial relationships | Zachi Attia: DO have relevant financial relationships ; Consultant:Anumana:Active (exists now) ; Consultant:Eko:Active (exists now) ; Consultant:AliveCor:Active (exists now) ; Ownership Interest:XAI.health:Active (exists now) | Paul Friedman: DO NOT have relevant financial relationships | Francisco Lopez-Jimenez: DO have relevant financial relationships ; Employee:Mayo Clinic:Active (exists now) ; Advisor:Select Research:Active (exists now) ; Advisor:WizeCare:Active (exists now) ; Consultant:Kento Health:Active (exists now) ; Advisor:Novo Nordisk:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Revolutionizing Cardiac Care: Machine Learning Innovations in ECG Analysis

Saturday, 11/16/2024 , 09:30AM - 10:55AM

Moderated Digital Poster Session

More abstracts on this topic:
Agreement of Doppler Flow Velocity Reserve With PET Flow Reserve in Angina Without Obstructive Coronaries

Ismayl Mahmoud, Raphael Claire, Prasad Abhiram, Chareonthaitawee Panithaya, Bois John

Ambient Air Pollution Heightens Prevalence and Adverse Impacts of Clonal Hematopoiesis of Indeterminate Potential

Abohashem Shady, Natarajan Pradeep, Tawakol Ahmed, Aldosoky Wesam, Uddin Md Mesbah, Civieri Giovanni, Lau Hui Chong, Abikaram Krystel, Assefa Alula, Rajagopalan Sanjay, Osborne Michael

More abstracts from these authors:
Uncovering Neighborhood-Level Inequities in Access to Transthoracic Echocardiograms

Medina-inojosa Betsy, Medina-inojosa Jose, Rajai Nazanin, Brewer Laprincess, Attia Zachi, Friedman Paul, Lerman Amir, Lopez-jimenez Francisco

Real-World Performance of the Artificial Intelligence-Enabled Electrocardiogram to Detect Increased Left Ventricular Filling Pressure to Predict Incidence of Heart Failure

Bhyravajosyula Sri Charan, Medina-inojosa Jose, Medina-inojosa Betsy, Lee Eunjung, Mangold Kathryn, Friedman Paul, Attia Zachi, Oh Jae, Lopez-jimenez Francisco

You have to be authorized to contact abstract author. Please, Login
Not Available